SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Paracelsian Inc (PRLN)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: John H. Farro who wrote (4205)3/7/1999 6:06:00 PM
From: FreedomForAll  Read Replies (1) of 4342
 
In the April issue of Liberty magazine there is an article about a lawsuit victory against the FDA. The US Court of Appeals in DC reversed an earlier decision saying that the FDA's requirements for health-claim approval process were unconstitutional under the First Amendment. (The article is not available online yet and is copywritten so I can't post it here.) This ruling as I understand it will allow companies to include on the labels of products, communication of studies that indicate positive results of use of the product. (The specific example used in the trial was the study that indicated that low doses of aspirin could reduce risk of heart attack.) I read this as being very positive news both for individuals and for companies like PRLN.

(The article is very interesting, as are others in Liberty. Its well worth the $4.)

David
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News